- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about psilocybin
Recent news which mentions psilocybin
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge
April 19, 2022
From Benzinga
Hawaii Lawmakers Advance Another Measure For Psilocybin Working Group: What You Need To Know
April 18, 2022
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
From Benzinga
Top 5 Most Influential Psychedelic Studies
March 29, 2022
From Benzinga
Is Wall Street The Next Stop For Psychedelics? Investing In The Psychedelic Medicine Sector
March 24, 2022
Tickers
MDMA
From Benzinga
Hawaii Passes And Amends Two Measures To Form Psilocybin Working Group, Move Research Forward
March 24, 2022
From Benzinga
From Benzinga
From Benzinga
Washington State Voters To Weigh In On 'Facilitated' Psilocybin Sessions: Advocates File Legalization Initiative
March 10, 2022
From Benzinga
From Benzinga
Hawaii: Senators Approve Task Force To Study Psilocybin Benefits Amid Shortage Of Medical Professionals
February 15, 2022
From Benzinga
Psychedelics Are Trending: If You Are Seeing Psilocybin In The Headlines Everywhere, You Are Right!
February 12, 2022
From Benzinga
Seattle Physician Launches Push To Reschedule Psilocybin For Medical Use
February 04, 2022
Tickers
DEA
From Benzinga
5 Psychedelics For Mental Health
February 01, 2022
From Benzinga
Cancer Patients' Case To Use Psilocybin Under Right To Try Law Dismissed By Fed Appeals Court
February 01, 2022
Tickers
NVMDF
From Benzinga
The Case For Psilocybin Therapy And Depression
January 30, 2022
From Benzinga
Texas Further Embraces Psychedelics With Launch Of Center For Psychedelic Research And Therapy
January 29, 2022
Tickers
MDMA
From Benzinga
Oklahoma: GOP Lawmakers File Bills To Decriminalize Psilocybin
January 25, 2022
From Benzinga
Two-Thirds Of Physicians Say Psilocybin Therapy Can Help Treatment-Resistant Depression, New Survey Shows
January 19, 2022
Tickers
CMPS
From Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
From Stock Gumshoe
Lawmakers Send Bipartisan Letter To DEA: Allow Psilocybin Treatment Under Right-To-Try Laws
January 18, 2022
From Benzinga
[Watch] How Psychedelics Will Change Society, MAPS Partnership With Numinus Wellness CEO
December 23, 2021
From Benzinga
EXCLUSIVE: Psychedelic Treatment Platform Maya Health Raises $4.3M, Bridging Clinical & Real-World Practices' Gap
December 17, 2021
Tickers
TECH
From Benzinga
Move Over Ganja, Magic Mushroom Retreats In Jamaica Now Happening Via Silo Wellness
December 16, 2021
Tickers
SILFF
From Benzinga
New York Lawmaker Files Bill To Legalize Psilocybin Treatments And License Treatment Centers
December 15, 2021
From Benzinga
DEA Raises Production Quota For Psychedelics Like MDMA, Psilocybin and DMT As Research Flourishes
December 02, 2021
Tickers
DEA
From Benzinga
COMPASS Pathways: Positive Psilocybin Trial, High-Dose Group Improves Beyond Depression Reduction
December 01, 2021
Tickers
CMPS
From Benzinga
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
November 23, 2021
Tickers
HAVLF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.